FDA Adverse Event Malfunction Summary report: N

ADVIA CENTAUR AFP ASSAY

MDR report key: 2863552 · Received December 10, 2012

Report

Report Number
1219913-2012-00405
Event Type
Malfunction
Date Received
December 10, 2012
Date of Event
November 10, 2012
Report Date
November 11, 2012
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Product Code
LOJ
PMA / PMN Number
K020806
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CT, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE CUSTOMER NOTICED THAT THE ADVIA CENTAUR AFP CALIBRATION AND CONTROLS WERE ERRATIC AND REMOVED THE ADVIA CENTAUR AFP REAGENT PACK FROM THE SYSTEM. THE PARAMAGNETIC PARTICLES WERE NOT SUSPENDED WELL AND THE MATERIAL WAS STUCK ON THE SIDES OF THE REAGENT PACK. THE CUSTOMER DISCONTINUED USING THE SYSTEM. THERE WERE NO ISSUES WITH THE OTHER ASSAYS. A SIEMENS FIELD SERVICE ENGINEER (FSE) WAS SENT TO THE CUSTOMER SITE FOR SYSTEM INSPECTION. ANOTHER AFP REAGENT PACK WAS INSPECTED AND PLACED ON THE SYSTEM AND THE FSE CHECKED THE CALIBRATION AND CONDUCTED TOTAL SERVICE AND FOUND NO SYSTEM ISSUES. THE SYSTEM WAS OPERATIONAL AND FULLY FUNCTIONAL UPON HIS DEPARTURE. THE CUSTOMER DID NOT REPORT ANY ADDITIONAL DISCORDANT RESULTS. THERE IS NO PATIENT SAMPLE AVAILABLE FOR FURTHER INVESTIGATION. THE CAUSE FOR THE DISCORDANT ADVIA CENTAUR AFP RESULT WAS MOST LIKELY DUE TO A CLUMPY AFP REAGENT PACK. THE INFORMATION FOR USE (IFU) STATES IN THE INTENDED USE SECTION: "WARNING: "USE AFP RESULTS ONLY AS PART OF THE OVERALL CLINICAL EVALUATION OF A PATIENT. DO NOT USE AFP RESULTS AS THE ONLY CRITERION FOR DIAGNOSIS." THE INFORMATION FOR USE (IFU) STATES IN THE LOADING REAGENTS SECTION: "MIX ALL PRIMARY REAGENT PACKS BY HAND BEFORE LOADING THEM ONTO THE SYSTEM. VISUALLY INSPECT THE BOTTOM OF THE REAGENT PACK TO ENSURE THAT ALL PARTICLES ARE DISPERSED AND RESUSPENDED."

Description of Event or Problem · 1

A LOW ADVIA CENTAUR XP AFP RESULT WAS OBTAINED ON A PATIENT SAMPLE AND REPORTED TO THE PHYSICIAN. THE LOW RESULTS WERE CONSIDERED DISCORDANT WHEN COMPARED TO REPEAT SAMPLE TESTING. THERE WAS NO REPORT OF PATIENT TREATMENT BEING PRESCRIBED OR ALTERED AND THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT ADVIA CENTAUR XP AFP RESULTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ADVIA CENTAUR AFP ASSAY AFP IMMUNOASSAY LOJ SIEMENS HEALTHCARE DIAGNOSTICS, INC. N/A 143

Patients

Seq Age Sex Outcome Treatment
1